Impact of Various Acceleration Techniques on En-masse Retraction of Maxillary Anterior Teeth (LLLT- piezo)

November 2, 2026 updated by: Alhassan Hatem Mohamed, Al-Azhar University

Impact of Various Acceleration Techniques on En-masse Retraction of Maxillary Anterior Teeth: A Digital Software Evaluation

Impact of Various Acceleration Techniques on En-masse Retraction of Maxillary Anterior Teeth: A Digital Software Evaluation (Comparative Clinical Study)

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This study will be conducted as a prospective, control, clinical trial, a convenience sampling technique was used for patient selection.

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 25 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age between 14 to 25.
  2. Patients who need upper or all four first premolar extraction for canine retraction.
  3. No systemic disease.
  4. No previous extraction of permanent teeth.
  5. Not receiving medical treatment that could interfere with bone metabolism.
  6. A good level of oral hygiene.
  7. No periodontal disease or radiographic evidence of bone loss

Exclusion Criteria:

1. Periodontally compromised patients. 2. Missing teeth. 3. Systemic diseases. 4. Drug dependencies. 5. Uncooperative patient.

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Retraction of Maxillary Anterior Teeth (en-mass) with conventional methods.
Procedure: Retraction of Maxillary Anterior Teeth (en-mass) with conventional methods.

Standard en-masse retraction using conventional orthodontic mechanics without adjunctive acceleration techniques.
Experimental: Retraction of Maxillary Anterior Teeth (en-mass) aided with low level LAZER therapy.
Device: low level LAZER therapy.

Application of low-level laser therapy (LLLT) as an adjunct to conventional en-masse retraction to accelerate tooth movement.
Experimental: Retraction of Maxillary Anterior Teeth (en-mass) aided with piezocision method.
Procedure: Piezocision-assisted orthodontic retraction

Minimally invasive surgical procedure (piezocision) used alongside conventional mechanics to facilitate accelerated tooth movement during en-masse retraction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact of Various Acceleration Techniques on En-masse Retraction of Maxillary Anterior Teeth
Time Frame: Base line (T0), 1 month (T1), 2months (T2), and 3months(T3) after the start of retraction

To evaluate and compare the rate and amount of en-masse retraction of maxillary anterior teeth using different orthodontic acceleration techniques through digital software analysis.
Base line (T0), 1 month (T1), 2months (T2), and 3months(T3) after the start of retraction

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Al-Azhar University

Investigators

  • Study Director: Mohamed Ahmed Salim, Professor, Al-Azhar University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

August 1, 2028

Study Registration Dates

First Submitted

July 22, 2025

First Submitted That Met QC Criteria

October 9, 2026

First Posted (Actual)

October 14, 2026

Study Record Updates

Last Update Posted (Actual)

November 4, 2026

Last Update Submitted That Met QC Criteria

November 2, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Alazhar U

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe